$50.60
-0.63-1.23%
Last update: Nov 12, 8:12 AM
GSK PLC (GSK) Stock Price, Quote, News & History
GSKNYSE
GSK beat Q3 analyst consensus with $1.47 adjusted EPS and $11.95 billion revenue, as specialty drugs offset vaccine drops. 2026 outlook reaffirmed.
You can purchase shares of GSK (NYSE:GSK) through any online brokerage.
Other companies in GSK’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
GSK has a consensus price target of $48.97.
The stock price for GSK (NYSE: GSK) is $50.79 last updated November 12, 2026 at 8:12 AM EST.
There are no upcoming dividends for GSK.
GSK does not have any upcoming earnings scheduled.
There is no upcoming split for GSK.
GSK is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and...
